Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn's disease

MLA

Franck Morel, et al. Distinct Expression of Interleukin (IL)-36α, β and γ, Their Antagonist IL-36Ra and IL-38 in Psoriasis, Rheumatoid Arthritis and Crohn’s Disease. Jan. 2016. EBSCOhost, https://doi.org/10.1111/cei.12761⟩.

APA

Franck Morel, Jérôme Amiaud, A. Bourreille, Marie-Astrid Boutet, Bénédicte Brulin, Céline Charrier, Maël Penhoat, M. Rolli‐Derkinderen, Frédéric Blanchard, B. Le Goff, Gaby Palmer, J.-C. Lecron, Géraldine Bart, Solenne Vigne, & Cem Gabay. (2016). Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn’s disease. https://doi.org/10.1111/cei.12761⟩

Chicago

Franck Morel, Jérôme Amiaud, A. Bourreille, Marie-Astrid Boutet, Bénédicte Brulin, Céline Charrier, Maël Penhoat, et al. 2016. “Distinct Expression of Interleukin (IL)-36α, β and γ, Their Antagonist IL-36Ra and IL-38 in Psoriasis, Rheumatoid Arthritis and Crohn’s Disease,” January. doi:10.1111/cei.12761⟩.